LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer

ABSTRACT: Background: There is no cure for castration-recurrent prostate cancer (CRPC) and the mechanisms underlying this stage of the disease are unknown. Methods: We analyzed the transcriptome of human LNCaP prostate cancer cells as they progress to CRPC in vivo using replicate LongSAGE libraries. We refer to these libraries as the LNCaP atlas and compared these gene expression profiles with current suggested models of CRPC. Results: Three million tags were sequenced using in vivo samples at various stages of hormonal progression to reveal 96 novel genes differentially expressed in CRPC. Thirty-one genes encode proteins that are either secreted or are located at the plasma membrane, 21 genes changed levels of expression in response to androgen, and 8 genes have enriched expression in the prostate.

ORGANISM(S): Homo sapiens

SUBMITTER: Marianne Sadar 

PROVIDER: E-GEOD-18402 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress